Table 1.

List of characteristics from the clinical records of the patients. * PC vs. PL, ** PC vs. BPH. N.S. (not significant): denote a result from a statistical hypothesis-testing procedure that does not allow the researcher to conclude that differences in the data obtained for different samples are meaningful.

	PC = 92	PL = 26	BPH = 49	SIGNIFICANCE
AGE	70 ± 7.86	68 ± 7.87	65 ± 8.17	** p = 0.009
PSA	21.28 ± 45.09	6.38 ± 4.57	6.87 ± 6.80	** p = 0.0013
INDEX	12 ± 5.59	20 ± 11.11	19.48 ± 10.18	* p = 0.009, ** p = 0.007
WBC	7.73 ± 2.14	6.46 ± 1.45	7.33 ± 2.26	N.S.
RBC	5.07 ± 0.59	5.18 ± 0.93	5.24 ± 0.51	N.S.
HGB	14.20 ± 1.64	14.67 ± 2.16	14.75 ± 1.26	N.S.
RDW	13.99 ± 1.51	13.51 ± 0.95	13.60 ± 0.99	N.S.
HDW	2.64 ± 0.41	2.55 ± 0.35	2.52 ± 0.30	N.S.
PLT	235.5 ± 66.15	217.35 ± 45.01	235.60 ± 55.80	N.S.
NEUT	4.88 ± 1.89	3.96 ± 1.33	4.45 ± 1.91	N.S.
LYMPH	1.97 ± 0.79	1.77 ± 0.50	2.04 ±0.79	N.S.
MONO	0.50 ± 0.17	0.43 ± 0.13	0.47 ± 0.15	N.S.
EOS	0.20 ± 0.14	0.17 ± 0.10	0.23 ± 0.15	N.S.
BASO	0.04 ± 0.05	0.02 ± 0.04	0.04 ± 0.05	N.S.
LUC#	0.14 ± 0.07	0.12 ± 0.04	0.14 ± 0.06	N.S.
LUC%	1.96 ± 0.73	2.03 ± 0.57	2.13 ± 0.74	N.S.
LMR	4.16 ± 1.50	4.49 ± 1.80	4.47 ± 1.40	N.S.
NLR	2.92 ± 1.85	2.51 ± 1.67	2.47 ± 1.24	N.S.
PLR	137.69 ± 63.58	131.05 ± 42.02	132.45 ± 58.93	N.S.
SIRI	1.50 ± 1.28	1.15 ± 0.99	1.19 ± 0.94	N.S.
AISI	367.07 ± 338.04	247.24 ± 206.44	292.39 ± 289.63	N.S.
PSA/AISI%	0.10 ± 0.26	0.04 ± 0.03	0.04 ± 0.04	N.S.
INDEX/SIRI	11.75 ± 11.98	24.10 ± 29.58	12.49 ± 15.34	N.S.
INDEX/AISI%	0.06 ± 0.07	0.12 ± 0.16	0.06 ± 0.07	N.S.
FAMILIARITY	8/92 (8.69%)	6/26 (23.07%)	6/49 (12.24%)	N.S.
CHARLSON	5.22 ± 1.62	2.47 ± 1.19	2.75 ± 1.37	* p = 0.02, ** p = 0.013
G6PDH DEFICIT	7/92 (7.60%)	3/26 (11.53%)	5/49 (10.2%)	N.S.
BMI	27.40 ± 3.67	26.87 ± 2.82	26.80 ± 4.01	N.S.
IPSS	11.88 ± 6.43	12 ± 8.51	12.93 ± 9.47	N.S.
IIEF	13.06 ± 7.40	17.29 ± 6.17	15.75 ± 8.43	* p = 0.02
TRUS	51.26 ± 24.98	60.31 ± 33.05	65.45 ± 35.46	** p = 0.009
SMOKE	32/92 (34.78%)	4/26 (15.38%)	13/49 (26.53%)	N.S.
ALCOHOL	1/92 (1.09%)	0/26 (0%)	2/49 (4.08%)	N.S.